Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1755)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4172)
  2. Weinberg Fellows (2756)
  3. Hematologic Malignancies, Division of (2492)
  4. Solid Tumor Oncology Division (2422)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (343)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT
    Meeting Abstract

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Application of the CIBMTR Survival Outcomes Calculator to CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Maloy, M.; Horowitz, M. M.; Rizzo, J. D.; Giralt, S. A.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells genetically engineered to deliver IL-12 to the tumor microenvironment in ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The immunomodulatory protein Dickkopf-1 (DKK1) defines a non-neuroendocrine subtype of metastatic castration-resistant prostate cancer (mCRPC) with low AR and low PSA expression
    Meeting Abstract

    Wise, D.; Armenia, J.; Chen, Y.; Nelson, P.; Schultz, N.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Longer follow-up on cardiac safety and distant disease free survival of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab in patients with early-stage HER2-positive breast cancer
    Meeting Abstract

    Wang, R.; Yu, A. F.; Steingart, R.; Patil, S.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. T.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Effect of cytarabine/anthracycline/crenolanib induction on minimal residual disease (MRD) in newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Stone, R. M.; Collins, R.; Tallman, M. S.; Walter, R. B.; Karanes, C.; Patel, P. A.; Vusirikala, M.; Coombs, C. C.; Olson, G.; Jain, V. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Combination of dabrafenib (DAB)
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Baxi, S. S.; Dunn, L.; Korte, S. H.; Haque, S.; Ghossein, R. A.; Chen, H. X.; Pfister, D. G.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save